Investor Relations - Smiths Group plc

Cookies

The cookie settings on this website are set to ‘allow all cookies’. Leaving your settings to ‘allow all cookies’ means you consent to a website remembering your preferences and generally enhancing the user experience. If you prefer a website to not remember your preferences, you can change your settings at any time by changing the privacy settings of your browser.

Find out more about cookies >

Our businesses are highly competitive and operate in sectors with excellent growth prospects. Strong cash-flow allows us to invest in the future development of our businesses, through both R&D and targeted acquisitions. 


10 July

Smiths Group completes divestment of Morpho Detection’s former trace business

Smiths Group completes divestment of Morpho Detection’s former trace business MORE

01 June

Smiths Group agrees to sell Morpho Detection’s former trace business

Smiths Group agrees to sell Morpho Detection’s former trace business MORE

23 May

Arrangements in respect of Chris O’Shea’s departure

Arrangements in respect of Chris O’Shea’s departure MORE

Proud to be Smiths video

Smiths colleagues tell our story

Watch the video

Corporate Video

Find out more about Smiths Group

Watch our corporate video

Interim results,
for period ended
31 January 2017

Press release

Webcast

Presentation

Jemma Spalton
Director of Investor Relations

Rebecca Cockram
Investor Relations Executive






back to top

Smiths Group divisions:

John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, Flex-Tek

Smiths Group plc:
Registered office 4th Floor, 11-12 St James’s Square, London, SW1Y 4LB
Incorporated in England No. 137013
Copyright 2017 Smiths Group plc.
All rights Reserved | Legal Notice | Privacy Policy | Cookie Policy